We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$765M
AUM Growth
-$490M
Cap. Flow
-$514M
Cap. Flow %
-67.23%
Top 10 Hldgs %
27.51%
Holding
553
New
233
Increased
66
Reduced
57
Closed
195

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$53.9M
2
TSEM icon
Tower Semiconductor
TSEM
+$39.6M
3
IBM icon
IBM
IBM
+$34.5M
4
DD icon
DuPont de Nemours
DD
+$30.1M
5
SWKS icon
Skyworks Solutions
SWKS
+$24.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.23%
2 Consumer Discretionary 14.53%
3 Financials 11.38%
4 Technology 9.88%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
1
HCA Healthcare
HCA
$83.7B
$34.9M 4.56%
474,964
-169,960
-26% -$11.9M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$23.3M 3.05%
+155,215
New +$22.4M
LEA icon
3
Lear
LEA
$7.2B
$22.7M 2.97%
231,941
+60,943
+36% +$5.6M
AJG icon
4
Arthur J. Gallagher & Co
AJG
$63.4B
$22.2M 2.9%
471,877
+257,256
+120% +$12.1M
TGNA
5
DELISTED
TEGNA Inc
TGNA
$20.8M 2.71%
1,242,302
+664,605
+115% +$10.7M
GRA
6
DELISTED
W.R. Grace & Co.
GRA
$20.7M 2.71%
217,377
+112,415
+107% +$10.5M
SPLK
7
DELISTED
Splunk Inc
SPLK
$19.8M 2.59%
+336,130
New +$20.6M
DVA icon
8
DaVita
DVA
$15.1B
$17.8M 2.32%
234,432
+42,984
+22% +$3.24M
PBYI icon
9
Puma Biotechnology
PBYI
$407M
$14.5M 1.9%
76,819
+20,187
+36% +$4.48M
TQNT
10
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$13.8M 1.8%
500,000
ENOV icon
11
Enovis
ENOV
$1.54B
$13.3M 1.73%
149,363
+50,655
+51% +$4.59M
EQIX icon
12
Equinix
EQIX
$108B
$11.6M 1.52%
51,161
+1,289
+3% +$279K
NLY icon
13
Annaly Capital Management
NLY
$16.8B
$10.8M 1.41%
249,983
+178
+0.1% +$8.05K
TLT icon
14
iShares 20+ Year Treasury Bond ETF
TLT
$42.2B
$10.1M 1.32%
+80,000
New +$9.7M
CGEN icon
15
Compugen
CGEN
$215M
$8.22M 1.07%
9,839
-22,562
-70% -$174K
KMDA icon
16
Kamada
KMDA
$408M
$7.49M 0.98%
+20,228
New +$76.7K
LBTYK icon
17
Liberty Global Class C
LBTYK
$3.19B
$7.24M 0.95%
185,150
-120,371
-39% -$4.39M
LUV icon
18
Southwest Airlines
LUV
$22.2B
$6.9M 0.9%
163,120
+154,343
+1,758% +$5.76M
CMCSA icon
19
Comcast
CMCSA
$80.1B
$6.49M 0.85%
223,716
+193,384
+638% +$5.3M
CHTR icon
20
Charter Communications
CHTR
$15.3B
$5.74M 0.75%
34,433
+19,969
+138% +$3.16M
BMS
21
DELISTED
Bemis
BMS
$5.6M 0.73%
+123,827
New +$4.99M
MAR icon
22
Marriott International
MAR
$98.7B
$5.42M 0.71%
69,501
+57,494
+479% +$4.24M
LMT icon
23
Lockheed Martin
LMT
$133B
$5.28M 0.69%
+27,431
New +$5.09M
CBST
24
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$5.15M 0.67%
+51,162
New +$3.98M
GD icon
25
General Dynamics
GD
$104B
$4.83M 0.63%
35,095
-27,224
-44% -$3.7M

Similar funds

LMR Partners's Q4 2014 Portfolio in Review

As of Q4 2014, LMR Partners held 553 positions worth $765M, down 39% from $1.26B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

LMR Partners withdrew a net $514M in Q4 2014, closing 195 positions and reducing 57 holdings. Its most notable exit was Oracle, an estimated $53.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, LMR Partners opened a new position in Berkshire Hathaway Class B worth $23.3M.

  • LMR Partners's largest Q4 2014 buy was Berkshire Hathaway Class B: 155,215 shares worth $23.3M.
  • LMR Partners added most to Arthur J. Gallagher & Co in Q4 2014, an estimated $12.1M increase.
  • LMR Partners's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $30.1M.
  • LMR Partners fully exited Oracle in Q4 2014, selling an estimated $53.9M.
  • LMR Partners's ten largest holdings make up 28% of its $765M portfolio in Q4 2014.
  • LMR Partners opened 233 new positions and closed 195 in Q4 2014.
  • LMR Partners's portfolio value fell 39% quarter-over-quarter to $765M.

Based on LMR Partners's 13F filing for Q4 2014, filed 20 Jan 2015.